I am/have/had
I am looking for
Advanced Filters
Found 1779 clinical trials
Featured trial
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine
The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.
acute treatment
migraine in children
lasmiditan
ly573144
migraine
- 0 views
- 19 Feb, 2024
